speb/financial-data huggingface dataset:
CTVA cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 234000000.00
CTVA balance_sheet (annual, 2023-12-31) — Inventory: 6899000000.00
CTVA balance_sheet (annual, 2023-12-31) — Invested Capital: 27525000000.00
CTVA cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1987000000.00
CTVA balance_sheet (annual, 2023-12-31) — Investments And Advances: 115000000.00
CTVA cash_flow (annual, 2023-12-31) — Issuance Of Debt: 3429000000.00
CTVA balance_sheet (annual, 2023-12-31) — Land And Improvements: 440000000.00
CTVA balance_sheet (annual, 2023-12-31) — Long Term Debt: 2291000000.00
CTVA balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2291000000.00
CTVA cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 3429000000.00
CTVA cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -2309000000.00
CTVA balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 115000000.00
CTVA balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 6315000000.00
CTVA balance_sheet (annual, 2023-12-31) — Minority Interest: 242000000.00
CTVA income_statement (annual, 2023-12-31) — Minority Interests: -12000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -1488000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -756000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income: 735000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 735000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 941000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -194000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 735000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 929000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 941000000.00
CTVA income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 747000000.00
CTVA income_statement (annual, 2023-12-31) — Net Interest Income: 50000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 41000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1114000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 1120000000.00
CTVA income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 50000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -49000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -2000000.00
CTVA balance_sheet (annual, 2023-12-31) — Net PPE: 4287000000.00
CTVA cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 57000000.00
CTVA cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -6000000.00
CTVA balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 4806000000.00
CTVA balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 584000000.00
CTVA balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 899000000.00
CTVA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 584000000.00
CTVA balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 899000000.00
CTVA balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2467000000.00
CTVA income_statement (annual, 2023-12-31) — Normalized EBITDA: 3248000000.00
CTVA income_statement (annual, 2023-12-31) — Normalized Income: 1541171000.00
CTVA cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1769000000.00
CTVA cash_flow (annual, 2023-12-31) — Operating Gains Losses: 116000000.00
CTVA income_statement (annual, 2023-12-31) — Operating Income: 2110000000.00
CTVA income_statement (annual, 2023-12-31) — Operating Revenue: 17226000000.00
CTVA balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 701260000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Current Assets: 1131000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 197000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2677000000.00
CTVA income_statement (annual, 2023-12-31) — Other Income Expense: -1067000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 9626000000.00
CTVA cash_flow (annual, 2023-12-31) — Other Non Cash Items: 765000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 1519000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 1651000000.00
CTVA income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -366000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Receivables: 1159000000.00
CTVA balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 98000000.00
CTVA balance_sheet (annual, 2023-12-31) — Payables: 4454000000.00
CTVA balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 6805000000.00
CTVA cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 138000000.00
CTVA income_statement (annual, 2023-12-31) — Pretax Income: 1093000000.00
CTVA cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 31000000.00
CTVA balance_sheet (annual, 2023-12-31) — Properties: 0.00
CTVA cash_flow (annual, 2023-12-31) — Purchase Of Business: -1488000000.00
CTVA cash_flow (annual, 2023-12-31) — Purchase Of Investment: -148000000.00
CTVA balance_sheet (annual, 2023-12-31) — Raw Materials: 851000000.00
CTVA balance_sheet (annual, 2023-12-31) — Receivables: 5488000000.00
CTVA income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 9392000000.00
CTVA income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1211000000.00
CTVA cash_flow (annual, 2023-12-31) — Repayment Of Debt: -2309000000.00
CTVA cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -756000000.00
CTVA income_statement (annual, 2023-12-31) — Research And Development: 1337000000.00
CTVA income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 336000000.00
CTVA balance_sheet (annual, 2023-12-31) — Retained Earnings: -41000000.00
CTVA cash_flow (annual, 2023-12-31) — Sale Of Investment: 189000000.00
CTVA cash_flow (annual, 2023-12-31) — Sale Of PPE: 57000000.00
CTVA income_statement (annual, 2023-12-31) — Selling General And Administration: 3176000000.00
CTVA balance_sheet (annual, 2023-12-31) — Share Issued: 701260000.00
CTVA income_statement (annual, 2023-12-31) — Special Income Charges: -314000000.00
CTVA balance_sheet (annual, 2023-12-31) — Stockholders Equity: 25037000000.00
CTVA balance_sheet (annual, 2023-12-31) — Tangible Book Value: 4806000000.00
CTVA income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -98829000.00
CTVA income_statement (annual, 2023-12-31) — Tax Provision: 152000000.00
CTVA income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.14
CTVA balance_sheet (annual, 2023-12-31) — Total Assets: 42996000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Capitalization: 27328000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Debt: 2489000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 25279000000.00
CTVA income_statement (annual, 2023-12-31) — Total Expenses: 15116000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 17717000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 26736000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 7308000000.00
CTVA balance_sheet (annual, 2023-12-31) — Total Tax Payable: 174000000.00
CTVA income_statement (annual, 2023-12-31) — Total Unusual Items: -711000000.00
CTVA income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -711000000.00
CTVA balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
CTVA balance_sheet (annual, 2023-12-31) — Work In Process: 2775000000.00
CTVA balance_sheet (annual, 2023-12-31) — Working Capital: 5851000000.00
CTVA balance_sheet (quarterly, 2024-09-30) — Commercial Paper: 2969000000.00
CTVA balance_sheet (quarterly, 2024-09-30) — Duefrom Related Parties Current: 145000000.00
CTVA income_statement (quarterly, 2024-09-30) — General And Administrative Expense: 708000000.00
CTVA balance_sheet (quarterly, 2024-09-30) — Line Of Credit: 0.00
CTVA cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: -7000000.00
CTVA balance_sheet (quarterly, 2024-09-30) — Net Debt: 3294000000.00
CTVA income_statement (quarterly, 2024-09-30) — Other Gand A: 671000000.00
CTVA cash_flow (quarterly, 2024-09-30) — Purchase Of Business: -7000000.00
CTVA income_statement (quarterly, 2024-09-30) — Salaries And Wages: 37000000.00
CTVA income_statement (annual, 2024-12-31) — +Operating Expense: 5283000000.00
CTVA income_statement (annual, 2024-12-31) — +Total Revenue: 16908000000.00
CTVA balance_sheet (annual, 2024-12-31) — Accounts Payable: 4039000000.00
CTVA balance_sheet (annual, 2024-12-31) — Accounts Receivable: 4615000000.00
CTVA balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -4975000000.00
CTVA balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 27196000000.00
CTVA balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -179000000.00
CTVA income_statement (annual, 2024-12-31) — Amortization: 685000000.00
CTVA cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 685000000.00
CTVA cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 685000000.00
CTVA income_statement (annual, 2024-12-31) — Amortization Of Intangibles Income Statement: 685000000.00
CTVA income_statement (annual, 2024-12-31) — Basic Average Shares: 693700000.00
CTVA income_statement (annual, 2024-12-31) — Basic EPS: 1.31
CTVA cash_flow (annual, 2024-12-31) — Beginning Cash Position: 3158000000.00
CTVA balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 1715000000.00
CTVA balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 1715000000.00
CTVA cash_flow (annual, 2024-12-31) — Capital Expenditure: -597000000.00
CTVA cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -597000000.00
CTVA balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 0.00
CTVA balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 0.00
CTVA balance_sheet (annual, 2024-12-31) — Capital Stock: 7000000.00
CTVA balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 3106000000.00
CTVA balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 3169000000.00
CTVA cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -458000000.00
CTVA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -1199000000.00
CTVA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -589000000.00
CTVA cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2296000000.00
CTVA cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -151000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Account Payable: -115000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Inventory: 1110000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -382000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Payable: -115000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -115000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Receivables: -705000000.00
CTVA cash_flow (annual, 2024-12-31) — Change In Working Capital: -92000000.00
CTVA cash_flow (annual, 2024-12-31) — Changes In Cash: 357000000.00
CTVA balance_sheet (annual, 2024-12-31) — Common Stock: 7000000.00
CTVA cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -458000000.00
CTVA cash_flow (quarterly, 2024-12-31) — Common Stock Dividend Paid: -118000000.00
CTVA balance_sheet (annual, 2024-12-31) — Common Stock Equity: 23789000000.00
CTVA cash_flow (annual, 2024-12-31) — Common Stock Payments: -1009000000.00
CTVA balance_sheet (annual, 2024-12-31) — Construction In Progress: 462000000.00
CTVA balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 462000000.00
CTVA income_statement (annual, 2024-12-31) — Cost Of Revenue: 9529000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2103000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Assets: 15097000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (annual, 2024-12-31) — Current Debt: 750000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 750000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 3287000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 3287000000.00
CTVA balance_sheet (annual, 2024-12-31) — Current Liabilities: 10386000000.00
CTVA cash_flow (annual, 2024-12-31) — Deferred Income Tax: -365000000.00
CTVA cash_flow (annual, 2024-12-31) — Deferred Tax: -365000000.00
CTVA cash_flow (annual, 2024-12-31) — Depreciation: 542000000.00
CTVA cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1227000000.00
CTVA income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 685000000.00
CTVA cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1227000000.00
CTVA income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 685000000.00
CTVA income_statement (annual, 2024-12-31) — Diluted Average Shares: 696000000.00
CTVA income_statement (annual, 2024-12-31) — Diluted EPS: 1.30
CTVA income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 907000000.00
CTVA income_statement (annual, 2024-12-31) — EBIT: 1508000000.00
CTVA income_statement (annual, 2024-12-31) — EBITDA: 2735000000.00
CTVA income_statement (annual, 2024-12-31) — Earnings From Equity Interest: 15000000.00
CTVA cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -93000000.00
CTVA balance_sheet (annual, 2024-12-31) — Employee Benefits: 2271000000.00
CTVA cash_flow (annual, 2024-12-31) — End Cash Position: 3422000000.00
CTVA cash_flow (annual, 2024-12-31) — Financing Cash Flow: -1199000000.00
CTVA balance_sheet (annual, 2024-12-31) — Finished Goods: 2649000000.00
CTVA cash_flow (annual, 2024-12-31) — Free Cash Flow: 1548000000.00
CTVA cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -17000000.00
CTVA income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 17000000.00
CTVA income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -284000000.00
CTVA balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -3469000000.00
CTVA balance_sheet (annual, 2024-12-31) — Goodwill: 10408000000.00
CTVA balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 19284000000.00
CTVA balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 4794000000.00
CTVA balance_sheet (annual, 2024-12-31) — Gross PPE: 9074000000.00
CTVA income_statement (annual, 2024-12-31) — Gross Profit: 7379000000.00
CTVA cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 707000000.00
CTVA balance_sheet (annual, 2024-12-31) — Income Tax Payable: 207000000.00
CTVA income_statement (annual, 2024-12-31) — Interest Expense: 233000000.00
CTVA income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 233000000.00
CTVA income_statement (annual, 2024-12-31) — Interest Income: 132000000.00
CTVA income_statement (annual, 2024-12-31) — Interest Income Non Operating: 132000000.00
CTVA cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 244000000.00
CTVA balance_sheet (annual, 2024-12-31) — Inventory: 5432000000.00
CTVA balance_sheet (annual, 2024-12-31) — Invested Capital: 26492000000.00
CTVA cash_flow (annual, 2024-12-31) — Investing Cash Flow: -589000000.00
CTVA balance_sheet (annual, 2024-12-31) — Investments And Advances: 134000000.00
CTVA cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3072000000.00
CTVA balance_sheet (annual, 2024-12-31) — Land And Improvements: 425000000.00
CTVA balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 425000000.00
CTVA balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
CTVA balance_sheet (annual, 2024-12-31) — Long Term Debt: 1953000000.00
CTVA balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1953000000.00
CTVA cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 3072000000.00
CTVA cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -2885000000.00
CTVA balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 134000000.00
CTVA balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 6472000000.00
CTVA balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 6472000000.00
CTVA balance_sheet (annual, 2024-12-31) — Minority Interest: 241000000.00
CTVA income_statement (annual, 2024-12-31) — Minority Interests: -12000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -7000000.00
CTVA cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CTVA cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -1009000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income: 907000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 907000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 863000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 56000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 907000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 851000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 863000000.00
CTVA income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 919000000.00
CTVA income_statement (annual, 2024-12-31) — Net Interest Income: -101000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 49000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 240000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 187000000.00
CTVA income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -101000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -32000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Other Investing Changes: -39000000.00
CTVA balance_sheet (annual, 2024-12-31) — Net PPE: 4099000000.00
CTVA cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 5000000.00
CTVA cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 53000000.00
CTVA balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 4505000000.00
CTVA balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 401000000.00
CTVA balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 478000000.00
CTVA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 401000000.00
CTVA balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 478000000.00
CTVA balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 2271000000.00
CTVA income_statement (annual, 2024-12-31) — Normalized EBITDA: 3290000000.00
CTVA income_statement (annual, 2024-12-31) — Normalized Income: 1226658823.53
CTVA cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2145000000.00
CTVA cash_flow (annual, 2024-12-31) — Operating Gains Losses: 143000000.00
CTVA cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 39000000.00
CTVA income_statement (annual, 2024-12-31) — Operating Income: 2096000000.00
CTVA income_statement (annual, 2024-12-31) — Operating Revenue: 16908000000.00
CTVA balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 685595000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Current Assets: 820000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 750000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -3469000000.00
CTVA income_statement (annual, 2024-12-31) — Other Income Expense: -720000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 8876000000.00
CTVA cash_flow (annual, 2024-12-31) — Other Non Cash Items: 520000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 1810000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1707000000.00
CTVA income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -180000000.00
CTVA income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: -87000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Receivables: 1061000000.00
CTVA balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 63000000.00
CTVA balance_sheet (annual, 2024-12-31) — Payables: 4246000000.00
CTVA balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6349000000.00
CTVA cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 160000000.00
CTVA income_statement (annual, 2024-12-31) — Pretax Income: 1275000000.00
CTVA cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 60000000.00
CTVA balance_sheet (annual, 2024-12-31) — Properties: 0.00
CTVA balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CTVA cash_flow (annual, 2024-12-31) — Purchase Of Business: -7000000.00
CTVA cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CTVA cash_flow (annual, 2024-12-31) — Purchase Of Investment: -144000000.00
CTVA cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -7000000.00
CTVA balance_sheet (annual, 2024-12-31) — Raw Materials: 486000000.00
CTVA balance_sheet (annual, 2024-12-31) — Receivables: 5676000000.00
CTVA income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 8987000000.00
CTVA income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1227000000.00
CTVA cash_flow (annual, 2024-12-31) — Repayment Of Debt: -2885000000.00
CTVA cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1009000000.00
CTVA income_statement (annual, 2024-12-31) — Research And Development: 1402000000.00
CTVA income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 288000000.00
CTVA balance_sheet (annual, 2024-12-31) — Retained Earnings: 55000000.00
CTVA cash_flow (annual, 2024-12-31) — Sale Of Investment: 193000000.00
CTVA cash_flow (annual, 2024-12-31) — Sale Of PPE: 5000000.00
CTVA income_statement (annual, 2024-12-31) — Selling General And Administration: 3196000000.00
CTVA balance_sheet (annual, 2024-12-31) — Share Issued: 685595000.00
CTVA income_statement (annual, 2024-12-31) — Special Income Charges: -271000000.00
CTVA balance_sheet (annual, 2024-12-31) — Stockholders Equity: 23789000000.00
CTVA balance_sheet (annual, 2024-12-31) — Tangible Book Value: 4505000000.00
CTVA income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -179341176.47
CTVA income_statement (annual, 2024-12-31) — Tax Provision: 412000000.00
CTVA income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.32
CTVA balance_sheet (annual, 2024-12-31) — Total Assets: 40825000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Capitalization: 25742000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Debt: 2703000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 24030000000.00
CTVA income_statement (annual, 2024-12-31) — Total Expenses: 14812000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 16795000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 25728000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 6409000000.00
CTVA balance_sheet (annual, 2024-12-31) — Total Tax Payable: 207000000.00
CTVA income_statement (annual, 2024-12-31) — Total Unusual Items: -555000000.00
CTVA income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -555000000.00
CTVA balance_sheet (annual, 2024-12-31) — Work In Process: 2297000000.00
CTVA balance_sheet (annual, 2024-12-31) — Working Capital: 4711000000.00
CTVA income_statement (quarterly, 2025-03-31) — +Operating Expense: 1248000000.00
CTVA income_statement (quarterly, 2025-03-31) — +Total Revenue: 4417000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3905000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7251000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5139000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 26962000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -190000000.00
CTVA income_statement (quarterly, 2025-03-31) — Amortization: 162000000.00
CTVA income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 162000000.00
CTVA income_statement (quarterly, 2025-03-31) — Basic Average Shares: 684900000.00
CTVA income_statement (quarterly, 2025-03-31) — Basic EPS: 0.95
CTVA cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3422000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -94000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -94000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 0.00
CTVA balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2008000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 2009000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -116000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 995000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -34000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2101000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: -8000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -190000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Inventory: 379000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -678000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Payable: -190000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -190000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Receivables: -2505000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -2994000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1148000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Commercial Paper: 1357000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Common Stock: 7000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -116000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 24285000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -270000000.00
CTVA income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2342000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2332000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Assets: 16587000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Debt: 2291000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2291000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 2631000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 2631000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 11481000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -122000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Deferred Tax: -122000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 296000000.00
CTVA income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 162000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 296000000.00
CTVA income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 162000000.00
CTVA income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 686600000.00
CTVA income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.95
CTVA income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 652000000.00
CTVA income_statement (quarterly, 2025-03-31) — EBIT: 820000000.00
CTVA income_statement (quarterly, 2025-03-31) — EBITDA: 1116000000.00
CTVA income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 11000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 21000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 2239000000.00
CTVA cash_flow (quarterly, 2025-03-31) — End Cash Position: 2295000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 995000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Finished Goods: 2827000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -2203000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -4000000.00
CTVA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: 4000000.00
CTVA income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -27000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -3271000000.00
CTVA income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 751000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Goodwill: 10332000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 19050000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 7441000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Gross PPE: 9244000000.00
CTVA income_statement (quarterly, 2025-03-31) — Gross Profit: 2075000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 322000000.00
CTVA income_statement (quarterly, 2025-03-31) — Interest Expense: 36000000.00
CTVA income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 36000000.00
CTVA income_statement (quarterly, 2025-03-31) — Interest Income: 32000000.00
CTVA income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 32000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Inventory: 5132000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Invested Capital: 28368000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -34000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 136000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 637000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Line Of Credit: 0.00
CTVA balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1792000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1792000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 637000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -14000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 136000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Minority Interest: 242000000.00
CTVA income_statement (quarterly, 2025-03-31) — Minority Interests: -4000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -270000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Net Debt: 2075000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income: 652000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 652000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 667000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -11000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 652000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 663000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 667000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 656000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Interest Income: -4000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 62000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 1368000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 623000000.00
CTVA income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -4000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -22000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -10000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Net PPE: 4105000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 8000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 745000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5235000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 413000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 369000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 413000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 369000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 2239000000.00
CTVA income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1161000000.00
CTVA income_statement (quarterly, 2025-03-31) — Normalized Income: 701284438.78
CTVA cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2109000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 6000000.00
CTVA income_statement (quarterly, 2025-03-31) — Operating Income: 827000000.00
CTVA income_statement (quarterly, 2025-03-31) — Operating Revenue: 4417000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 683026000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1152000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 934000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -3271000000.00
CTVA income_statement (quarterly, 2025-03-31) — Other Gand A: 751000000.00
CTVA income_statement (quarterly, 2025-03-31) — Other Income Expense: -39000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 8718000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 46000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1832000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1715000000.00
CTVA income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -5000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1043000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Payables: 4227000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 6559000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Pension And Employee Benefit Expense: 10000000.00
CTVA income_statement (quarterly, 2025-03-31) — Pretax Income: 784000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 35000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
CTVA cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
CTVA balance_sheet (quarterly, 2025-03-31) — Raw Materials: 424000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Receivables: 8294000000.00
CTVA income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2208000000.00
CTVA income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 296000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -14000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -270000000.00
CTVA income_statement (quarterly, 2025-03-31) — Research And Development: 335000000.00
CTVA income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 22000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 587000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 62000000.00
CTVA cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 8000000.00
CTVA income_statement (quarterly, 2025-03-31) — Selling General And Administration: 751000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Share Issued: 683026000.00
CTVA income_statement (quarterly, 2025-03-31) — Special Income Charges: -18000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 24285000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5235000000.00
CTVA income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -6715561.22
CTVA income_statement (quarterly, 2025-03-31) — Tax Provision: 117000000.00
CTVA income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
CTVA balance_sheet (quarterly, 2025-03-31) — Total Assets: 42123000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 26077000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Debt: 4083000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 24527000000.00
CTVA income_statement (quarterly, 2025-03-31) — Total Expenses: 3590000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 17596000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 25536000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6115000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 322000000.00
CTVA income_statement (quarterly, 2025-03-31) — Total Unusual Items: -45000000.00
CTVA income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -45000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Work In Process: 1881000000.00
CTVA balance_sheet (quarterly, 2025-03-31) — Working Capital: 5106000000.00
CTVA income_statement (quarterly, 2025-06-30) — +Operating Expense: 1692000000.00
CTVA income_statement (quarterly, 2025-06-30) — +Total Revenue: 6456000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3828000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 7358000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -5302000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 27014000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -218000000.00
CTVA income_statement (quarterly, 2025-06-30) — Amortization: 161000000.00
CTVA income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 161000000.00
CTVA income_statement (quarterly, 2025-06-30) — Basic Average Shares: 681700000.00
CTVA income_statement (quarterly, 2025-06-30) — Basic EPS: 1.92
CTVA cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2295000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -118000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -118000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 0.00
CTVA balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 2065000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 2141000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -116000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -808000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -164000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 962000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: -15000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -166000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Inventory: 931000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -1599000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Payable: -166000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -166000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Receivables: -39000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -873000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Changes In Cash: -25000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Commercial Paper: 460000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Common Stock: 7000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -116000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 25909000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -250000000.00
CTVA income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2932000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 2903000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Assets: 16004000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 0.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Debt: 1942000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 1942000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 358000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 358000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 9516000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -87000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Deferred Tax: -87000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 301000000.00
CTVA income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 161000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 301000000.00
CTVA income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 161000000.00
CTVA income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 683100000.00
CTVA income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.92
CTVA income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 1314000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Duefrom Related Parties Current: 107000000.00
CTVA income_statement (quarterly, 2025-06-30) — EBIT: 1856000000.00
CTVA income_statement (quarterly, 2025-06-30) — EBITDA: 2157000000.00
CTVA income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -1000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 47000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 2229000000.00
CTVA cash_flow (quarterly, 2025-06-30) — End Cash Position: 2317000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -808000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Finished Goods: 1934000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 829000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -13000000.00
CTVA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Business: 13000000.00
CTVA income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -25000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2644000000.00
CTVA income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1156000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Goodwill: 10518000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 19101000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 7576000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Gross PPE: 9455000000.00
CTVA income_statement (quarterly, 2025-06-30) — Gross Profit: 3524000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 485000000.00
CTVA income_statement (quarterly, 2025-06-30) — Interest Expense: 52000000.00
CTVA income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 52000000.00
CTVA income_statement (quarterly, 2025-06-30) — Interest Income: 31000000.00
CTVA income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 31000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Inventory: 4316000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Invested Capital: 29538000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -164000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 134000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 577000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 0.00
CTVA balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1687000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1687000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 577000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -321000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 134000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Minority Interest: 242000000.00
CTVA income_statement (quarterly, 2025-06-30) — Minority Interests: -2000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -250000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Net Debt: 1564000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income: 1314000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 1314000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 1382000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -66000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 1314000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 1380000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 1382000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 1316000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Interest Income: -21000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -56000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -461000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 256000000.00
CTVA income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -21000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -16000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -7000000.00
CTVA balance_sheet (quarterly, 2025-06-30) — Net PPE: 4153000000.00
CTVA cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 17000000.00